Thiogenesis Therapeutics Market Cap

Thiogenesis Therapeutics has a market cap or net worth of CAD 31.40 million as of February 21, 2025. Its market cap has increased by 1.00% in one year.

Market Cap

31.40M

Enterprise Value

27.25M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

0.69

Market Cap Chart

Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 31.40M, an increase of 125.02%. That is a compound annual growth rate of 32.75%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	31.40M	15.00%
Dec 31, 2024	27.31M	-18.31%
Dec 29, 2023	33.43M	48.30%
Dec 30, 2022	22.54M	61.52%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Green Thumb Industries	2.41B
Curaleaf Holdings	1.55B
WELL Health Technologies	1.53B
dentalcorp Holdings	1.53B
Sienna Senior Living	1.27B
Trulieve Cannabis	1.19B
Cronos Group	1.06B
Extendicare	955.70M

Market Cap Rankings